Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2
- PMID: 12808141
- PMCID: PMC164693
- DOI: 10.1073/pnas.1331358100
Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2
Abstract
Mice lacking the chemokine receptor chemotactic cytokine receptor 2 (CCR2) have a marked attenuation of monocyte recruitment in response to various inflammatory stimuli and a reduction of inflammatory lesions in models of demyelinating disease. In the present study, we compared nociceptive responses in inflammatory and neuropathic models of pain in CCR2 knockout and wild-type mice. In acute pain tests, responses were equivalent in CCR2 knockout and wild-type mice. In models of inflammatory pain, CCR2 knockout mice showed a 70% reduction in phase 2 of the intraplantar formalin-evoked pain response but only a modest (20-30%) and nonsignificant reduction of mechanical allodynia after intraplantar Freund's adjuvant (CFA). In a model of neuropathic pain, the development of mechanical allodynia was totally abrogated in CCR2 knockout mice. CFA administration induced marked up-regulation of CCR2 mRNA in the skin and a moderate increase in the sciatic nerve and dorsal root ganglia (DRG). In response to nerve ligation, persistent and marked up-regulation of CCR2 mRNA was evident in the nerve and DRG. Disruption of Schwann cells in response to nerve lesion resulted in infiltration of CCR2-positive monocytes/macrophages not only to the neuroma but also to the DRG. Chronic pain also resulted in the appearance of activated CCR2-positive microglia in the spinal cord. Collectively, these data suggest that the recruitment and activation of macrophages and microglia peripherally and in neural tissue may contribute to both inflammatory and neuropathic pain states. Accordingly, blockade of the CCR2 receptor may provide a novel therapeutic modality for the treatment of chronic pain.
Figures




Similar articles
-
Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses.Neuroscience. 2007 Nov 9;149(3):706-14. doi: 10.1016/j.neuroscience.2007.08.014. Epub 2007 Aug 14. Neuroscience. 2007. PMID: 17870246
-
Monocyte recruitment and myelin removal are delayed following spinal cord injury in mice with CCR2 chemokine receptor deletion.J Neurosci Res. 2002 Jun 15;68(6):691-702. doi: 10.1002/jnr.10269. J Neurosci Res. 2002. PMID: 12111830
-
Comparison of gene expression profiles in neuropathic and inflammatory pain.J Physiol Pharmacol. 2006 Sep;57(3):401-14. J Physiol Pharmacol. 2006. PMID: 17033093
-
Role of the immune system in neuropathic pain.Scand J Pain. 2019 Dec 18;20(1):33-37. doi: 10.1515/sjpain-2019-0138. Scand J Pain. 2019. PMID: 31730538 Review.
-
Chemokine signaling and the management of neuropathic pain.Mol Interv. 2009 Aug;9(4):188-95. doi: 10.1124/mi.9.4.7. Mol Interv. 2009. PMID: 19720751 Free PMC article. Review.
Cited by
-
The brain's best friend: microglial neurotoxicity revisited.Front Cell Neurosci. 2013 May 16;7:71. doi: 10.3389/fncel.2013.00071. eCollection 2013. Front Cell Neurosci. 2013. PMID: 23734099 Free PMC article.
-
Novel Therapeutic Targets in Neuroinflammation and Neuropathic Pain.Inflamm Cell Signal. 2014;1(3):e111. doi: 10.14800/ics.111. Inflamm Cell Signal. 2014. PMID: 26052540 Free PMC article.
-
Interferon-gamma potentiates NMDA receptor signaling in spinal dorsal horn neurons via microglia-neuron interaction.Mol Pain. 2016 Apr 18;12:1744806916644927. doi: 10.1177/1744806916644927. Print 2016. Mol Pain. 2016. PMID: 27094552 Free PMC article.
-
Adoptive transfer of M2 macrophages reduces neuropathic pain via opioid peptides.J Neuroinflammation. 2016 Oct 7;13(1):262. doi: 10.1186/s12974-016-0735-z. J Neuroinflammation. 2016. PMID: 27717401 Free PMC article.
-
CCL2 promotes P2X4 receptor trafficking to the cell surface of microglia.Purinergic Signal. 2012 Jun;8(2):301-10. doi: 10.1007/s11302-011-9288-x. Epub 2012 Jan 6. Purinergic Signal. 2012. PMID: 22222817 Free PMC article.
References
-
- Onuffer, J. & Horuk, R. (2002) Trends Pharmacol. Sci. 23, 459-467. - PubMed
-
- Ma, M., Wei, T., Boring, L., Charo, I. F., Ransohoff, R. M. & Jakeman, L. B. (2002) J. Neurosci. Res. 68, 691-702. - PubMed
-
- Siebert, H., Sachse, A., Kuziel, W. A., Maeda, N. & Bruck, W. (2000) J. Neuroimmunol. 110, 177-185. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases